NUREG-1556 Volume 13, Rev 2 - Consolidated Guidance About Materials Licenses - Program-Specific Guidance About Commercial Radiopharmacy Licenses - Final Report: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
(Created page by program invented by StriderTol)
Line 3: Line 3:
| issue date = 03/31/2019
| issue date = 03/31/2019
| title = NUREG-1556 Volume 13, Rev 2 - Consolidated Guidance About Materials Licenses - Program-Specific Guidance About Commercial Radiopharmacy Licenses - Final Report
| title = NUREG-1556 Volume 13, Rev 2 - Consolidated Guidance About Materials Licenses - Program-Specific Guidance About Commercial Radiopharmacy Licenses - Final Report
| author name = Elliott R L, Gattone R G, Graham C, Katanic J F, McMurtray A C, Roldan-Otero L, Thompson T
| author name = Elliott R, Gattone R, Graham C, Katanic J, McMurtray A, Roldan-Otero L, Thompson T
| author affiliation = NRC/NMSS
| author affiliation = NRC/NMSS
| addressee name =  
| addressee name =  

Revision as of 08:56, 12 June 2019

NUREG-1556 Volume 13, Rev 2 - Consolidated Guidance About Materials Licenses - Program-Specific Guidance About Commercial Radiopharmacy Licenses - Final Report
ML19079A207
Person / Time
Issue date: 03/31/2019
From: Robert Elliott, Gattone R, Graham C, Janine Katanic, McMurtray A, Lizette Roldan-Otero, Thompson T
Office of Nuclear Material Safety and Safeguards
To:
Meyd, Donald
References
NUREG V13 R2, NUREG-1556, Vol. 13, Rev. 2
Download: ML19079A207 (289)